S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in

NYSE:CL - Colgate-Palmolive Stock Price, Forecast & News

$70.61
+0.08 (+0.11 %)
(As of 01/23/2020 04:00 PM ET)
Today's Range
$70.00
Now: $70.61
$71.07
50-Day Range
$67.22
MA: $69.10
$71.29
52-Week Range
$60.96
Now: $70.61
$76.41
Volume2.58 million shs
Average Volume3.99 million shs
Market Capitalization$60.52 billion
P/E Ratio26.15
Dividend Yield2.44%
Beta0.71
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. Read More…

Industry, Sector and Symbol

Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
CUSIP19416210
Phone212-310-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.54 billion
Cash Flow$3.56 per share
Book Value$0.23 per share

Profitability

Net Income$2.40 billion

Miscellaneous

Employees34,500
Market Cap$60.52 billion
Next Earnings Date1/31/2020 (Confirmed)
OptionableOptionable

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.


Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, January 9th. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.43 per share on Friday, February 14th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Wednesday, January 22nd. View Colgate-Palmolive's Dividend History.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive declared that its board has initiated a share repurchase plan on Monday, June 18th 2018, which allows the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) released its quarterly earnings results on Friday, November, 1st. The company reported $0.71 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.70 by $0.01. The company had revenue of $3.93 billion for the quarter, compared to analysts' expectations of $3.95 billion. Colgate-Palmolive had a return on equity of 6,492.71% and a net margin of 15.04%. The business's revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.72 earnings per share. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January 31st 2020. View Earnings Estimates for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, January 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for CL?

14 Wall Street analysts have issued 12 month target prices for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $82.00. On average, they expect Colgate-Palmolive's share price to reach $73.08 in the next year. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.

What is the consensus analysts' recommendation for Colgate-Palmolive?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:
  • 1. According to Zacks Investment Research, "Shares of Colgate have declined and underperformed the industry in the past six months, driven by its strained margin trend. In third-quarter 2019, escalated expenses of raw and packaging materials, including foreign-currency transaction costs, hurt gross margin. This coupled with higher SG&A expenses, as a rate of sales, hurt operating profits. Consequently, earnings fell year over year and are likely to decline in mid-single digits in 2019. Also, adverse currency impacts cannot be ignored. Nevertheless, Colgate expects strong top-line gains from accelerated investments in brands, pricing and innovation along with expansion in new markets and e-commerce capabilities. Moreover, it expects to sustain organic sales growth trend in 2019, backed by higher volume and pricing. Management now estimates organic sales growth of 3-4%." (11/4/2019)
  • 2. Wells Fargo & Co analysts commented, "We are raising our price target by $3 to $68 to reflect CL’s fundamental progress to date, but maintain our Market Perform rating largely on valuation." (6/17/2019)

Has Colgate-Palmolive been receiving favorable news coverage?

News coverage about CL stock has trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Colgate-Palmolive earned a daily sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Colgate-Palmolive.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 13,460,000 shares, a drop of 5.5% from the December 15th total of 14,250,000 shares. Based on an average daily volume of 3,670,000 shares, the days-to-cover ratio is presently 3.7 days. Currently, 1.6% of the shares of the stock are sold short. View Colgate-Palmolive's Current Options Chain.

Who are some of Colgate-Palmolive's key competitors?

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), AT&T (T), Walt Disney (DIS), The Coca-Cola (KO), Mcdonald's (MCD), Verizon Communications (VZ), Exxon Mobil (XOM) and Intel (INTC).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:
  • Mr. Ian M. Cook, Exec. Chairman (Age 66)
  • Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
  • Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
  • Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
  • Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by many different of retail and institutional investors. Top institutional shareholders include LGT Capital Partners LTD. (0.15%), Marathon Asset Management LLP (0.12%), PGGM Investments (0.10%), Boston Trust Walden Corp (0.07%), Gateway Investment Advisers LLC (0.06%) and Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.06%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Institutional Ownership Trends for Colgate-Palmolive.

Which institutional investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Manning & Napier Group LLC, KAMES CAPITAL plc, Tocqueville Asset Management L.P., Marathon Asset Management LLP, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA and Gateway Investment Advisers LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Dennis J Hickey, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive.

Which institutional investors are buying Colgate-Palmolive stock?

CL stock was acquired by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD., Pensionfund DSM Netherlands, Baxter Bros Inc., United Services Automobile Association, Townsend & Associates Inc, Johanson Financial Advisors Inc., Pensionfund Sabic and Janney Montgomery Scott LLC. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $70.61.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $60.52 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.View Additional Information About Colgate-Palmolive.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is http://www.colgatepalmolive.com/.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]


MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  446 (Vote Outperform)
Underperform Votes:  836 (Vote Underperform)
Total Votes:  1,282
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel